Go Pro
NASDAQ:BLFS

BioLife Solutions Q2 2026 Earnings Report

BioLife Solutions logo
$39.15 +0.66 (+1.71%)
Closing price 09/28/2026 04:00 PM Eastern
Extended Trading
$39.15 0.00 (0.00%)
As of 09/28/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BioLife Solutions EPS Results

Actual EPS
$0.91
Consensus EPS
$0.03
Beat/Miss
Beat by +$0.88
One Year Ago EPS
N/A

BioLife Solutions Revenue Results

Actual Revenue
$28.47 million
Expected Revenue
$27.80 million
Beat/Miss
Beat by +$670.00 thousand
YoY Revenue Growth
N/A

BioLife Solutions Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
Thursday, August 6, 2026
Conference Call Time
4:00PM ET

Upcoming Earnings

BioLife Solutions' Q3 2026 earnings is estimated for Thursday, November 5, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

BioLife Solutions Earnings Headlines

Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
See More BioLife Solutions Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioLife Solutions? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioLife Solutions and other key companies, straight to your email.

About BioLife Solutions

BioLife Solutions (NASDAQ:BLFS) develops and supplies tools and services used in the development, manufacture, preservation and distribution of cell and gene therapies. Its products are designed to help maintain the viability and functionality of cells, tissues and other biological materials during processing, freezing, storage and transportation.

The company’s portfolio includes cell and tissue preservation media, thawing and processing solutions, cryogenic storage systems, controlled-rate freezing equipment and related bioproduction technologies. Its brands and offerings support applications such as cell therapy, gene therapy, regenerative medicine, biobanking and other life sciences workflows.

BioLife Solutions serves pharmaceutical and biotechnology companies, contract development and manufacturing organizations, academic and research institutions, hospitals and other healthcare organizations. The company has expanded its offerings through acquisitions and product development, with operations and customers serving the global life sciences market.

View BioLife Solutions Profile